LGND
Ligand Pharmaceuticals Inc.
stockNASDAQ
At CloseOct 16, 2026 3:59:58 PM EDT
295.72USD-0.931%(-2.78)164,511
Loading…
Loading…
5.89B
Healthcare
Biotechnology
CEO
John Higgins
HQ
San Diego, CA, USA
Previous Close
$298.50
Beta
0.78
52-Week High
$326.63 2026-07-08
52-Week Low
$175.89 2026-01-13
SMA 50
$292.45
SMA 200
$246.94
Avg. Vol 10D
225,713
Avg. Vol 30D
253,987
Avg. Vol 90D
328,533
Relative Vol
0.65
19.94M
19.49M
97.76%
2,677,998
13.70%
8.73
51%/49%
74.33%
61.61%
0.4100%
100,000
156
988
5,586
Oct 29, 2026 (11d)
Apr 3, 2007 · $2.500
Nov 19, 2010 · 1-for-5.9999 (reverse)
Oct 15, 2026
Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 · 
GlobeNewswire Inc.
Oct 1, 2026
StoneX updates its best ideas list · 
Seeking Alpha
Sep 25, 2026
Sep 24, 2026
LGND Profile
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
LGND Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 301.81 | 2026-10-09 | -2.07% | 2.086 |
| 1M | 284.70 | 2026-09-17 | +3.81% | 0.647 |
| 3M | 303.39 | 2026-07-17 | -2.58% | 1.004 |
| 6M | 231.82 | 2026-04-17 | +27.50% | 0.664 |
| 1Y | 181.65 | 2025-10-17 | +62.71% | 0.776 |
| 2Y | 105.89 | 2024-10-17 | +179.12% | — |
| 5Y | 128.57 | 2021-10-18 | +129.88% | 1.104 |
LGND Stock Summary
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $295.56, and today's volume is 164,511. LGND is down 0.985% today. The 30 day average volume is 253,987. LGND market cap is $5.89B with 19.94M shares outstanding.